NCT01087398 arm group c143a2430949511de6ed78cf1c63afc9 [clinicaltrials_resource:NCT01087398/arm-group/c143a2430949511de6ed78cf1c63afc9]
Busulfan, Cyclophosphamide, Thymoglobulin, Fludarabine (Conditioning regimen) [clinicaltrials_resource:98e38fa04cebbb4dbaa9013f6721952d]Cyclosporin, Methotrexate (GVHD prophylaxis) [clinicaltrials_resource:9e03c5748374950cc378e6a817de4428]Stem Cell Transplantation [clinicaltrials_resource:d1fb6d5ff4ff0d371c86dd9bd4e13b97]Hematopoietic Stem Cell Transplantation for Malignant Infantile Osteopetrosis [clinicaltrials:NCT01087398]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01087398 arm group c143a2430949511de6ed78cf1c63afc9 [clinicaltrials_resource:NCT01087398/arm-group/c143a2430949511de6ed78cf1c63afc9]
Bio2RDF identifier
NCT01087398/arm-group/c143a2430949511de6ed78cf1c63afc9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 43a2430949511de6ed78cf1c63afc9
identifier
clinicaltrials_resource:NCT01087398/arm-group/c143a2430949511de6ed78cf1c63afc9
title
NCT01087398 arm group c143a2430949511de6ed78cf1c63afc9
@en
type
label
NCT01087398 arm group c143a243 ...... 3a2430949511de6ed78cf1c63afc9]
@en